View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 400 / Lenvatinib 20, Adenocarcinoma Esophagogastric Junction and Stomach, Cycle 3-18
Protocol-ID: 2949 V1.0 (Mini), PEMB400/LENV20, AEG/Gastric Ca, C3-18Indication(s)
- Gastric Cancer; ICD-10 C16.-, C16.0
- Esophageal Cancer; ICD-10 C15.-
Adenocarcinoma of the esophagogastric junction (AEG)
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 10.06.2025